Broker tips: Debenhams, Gym Group, Tullow Oil, Ophir Energy

Alexander Bueso WebFG News | 19 Sep, 2017 17:44 - Updated: 17:44 | | |

barclays-devant-la-justice-britannique-dans-l-affaire-libor

Debenhams

33.00

17:20 12/12/17
0.76%
0.25
  • 2,463.34
  • -0.46%-11.27
  • Max: 2,481.60
  • Min: 2,453.54
  • Volume: 0
  • MM 200 : n/a
17:20 12/12/17
  • 5,771.90
  • 0.43%24.57
  • Max: 5,771.90
  • Min: 5,747.33
  • Volume: 0
  • MM 200 : n/a
17:20 12/12/17
  • 4,114.09
  • 0.53%21.50
  • Max: 4,114.10
  • Min: 4,090.46
  • Volume: 0
  • MM 200 : n/a
17:30 12/12/17

Investec reiterated its 'sell' recommendation on Debenham's on the back of expectations for foreign exchange headwinds, unanswered questions around execution and profitability and the ongoing shift towards 'on-line'.

Indeed, the dividend might not be "sustainable".

In a research report published following a visit to the outfit's new store in Stevenage, which they dubbed a 'work-in-progess' lab, analysts Kate Calvert and Alistair Davies said the company's fiscal year results on 26 October were unlikely to be a share price trigger.

On a more positive note, they admitted that profits before tax might come in ahead of company guidance of "towards the bottom of the market range if volatility continues".

However, they added that: "Many unanswered questions around execution and profitability mean it is difficult to forecast with any confidence."

As well, the company's hedging policy meant FX headwinds would be at their worst in the first half of 2018, they wrote.

Barclays Research upped its target on shares of Gym Group from 230p to 250p following its first acquisition since the group floated, purchasing 18 gyms from Lifestyle Fitness.

On the downside, the transaction was seen diluting the company's overall return-on-capital-employed, with 20% expected from the deal versus a target EBITDA ROCE of 30% on those sites which it added organically.

There were also potential integration risks which management might have to navigate.

Offsetting those were numerous potential positives, including adding a year's-worth of organic growth "instantly", significant earnings accretion on a per share basis, and attractive rents on the new sites which should bolster EBITDA.

Hence, Barclays retained its 'overweight' stance on the stock, adding that the EBITDA ROCE on offer was still attractive, while highlighting that by buying assets the company would reach cash payback more quickly than if it opted to build out organically.


Analysts at Credit Suisse rejigged their recommendations for European Exploration and Production outfits, telling clients the sector was better positioned to emerge from the cycle, while its year-to-date de-rating had made it more "attractive".

On the basis of the above, shares of Tullow Oil were lifted to 'outperform' (with a target price 210p, versus 205p previously) on valuation grounds and due to catalysts now lying closer on the horizon.

Cairn (CS's 'top-pick' with an unchanged target of 260p), Nostrum and Aker BP (target steady at 170p)were all kept at 'outperform'.
However, Nostrum's target was cut from 545p to 460p.

As a group, companies in the space were facing off against two challenges, worsening investor sentiment despite an improved oil price outlook and the need to position themselves operationally on the global cost curve relative to US shale rivals.

"International E&Ps are pricing in a long-term oil price of $57/bbl, on our estimates, vs. the forward curve at $54/bbl. Valuations have become more attractive compared to when we initiated on the sector," the Swiss broker observed.

More news

12 Dec US close: Markets mixed as Fed finishes first day of meeting

Wall Street's main indices finished mixed on Tuesday as the Federal Reserve kicked off its two-day rate-setting meeting, alongside several positive updates from corporate heavyweights such as Boeing and 3M.

12 Dec Theresa May unveils new climate change policies in Paris summit

Prime Minister Theresa May has announced new environmental policies including a £140m fund to help developing countries battle against the negative effects of climate change.

12 Dec Broker tips: Lloyds, Barclays, Entertainment One

Goldman Sachs reiterated its 'sell' recommendation on shares of Lloyds and Barclays, placing both stocks on its list of 'UK Sell Ideas' for 2018.

12 Dec Results round-up

Industrial equipment rental firm Ashtead said half year earnings were boosted by clean-up efforts after hurricanes Harvey, Irma and Maria and the weak pound as it posted a 16% rise in pre-tax profits to £493.1m.

12 Dec Europe close: Technology and M&A power gains in shares

Stocks on the Continent gained ground on Tuesday paced by Technology issues, even as traders waited on the US central bank's policy announcement the next day.

12 Dec London close: Forties failure lifts FTSE as inflation spikes

London stocks extended their gains on Tuesday as supply disruptions boosted the energy sector and investors mulled higher than expected UK inflation figures.

12 Dec US open: Boeing, 3M push Dow Industrials to fresh record-high

Wall Street's main indices are again heading higher on Tuesday as the Federal Reserve kicks off its two-day rate-setting meeting and several positive updates from corporate heavyweights such as Boeing and 3M.

12 Dec EasyJet acquisition of Air Berlin assets approved by European Commission

UK budget airline easyJet cleared a major regulatory hurdle on Tuesday as its proposed acquisition of airport slots and aircraft from Air Berlin was approved by the European Commission.

12 Dec Facebook to overhaul its tax structure worldwide

Facebook will move its global tax and revenue base from Ireland and begin booking advertising locally in every country where it operates.

12 Dec GSK given green light for Churg-Strauss syndrome treatment

GlaxoSmithKline has been given approval by the US drug regulator for a first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome.